Proceedings of the International Conference on Bioreductive Drug Activation: Lake Tahoe, Ca., USA, August 16 - 19, 1994
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
New York
Pergamon
1994
|
| Schriftenreihe: | Oncology research
6,10/11 |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zs.-Heftes |
| Beschreibung: | S. 459 - 559 graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010583554 | ||
| 003 | DE-604 | ||
| 007 | t| | ||
| 008 | 960124s1994 xx d||| |||| 10||| engod | ||
| 035 | |a (OCoLC)645862808 | ||
| 035 | |a (DE-599)BVBBV010583554 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 111 | 2 | |a International Conference on Bioreductive Drug Activation |d 1994 |c Tahoe City, Calif. |j Verfasser |0 (DE-588)1230946-1 |4 aut | |
| 245 | 1 | 0 | |a Proceedings of the International Conference on Bioreductive Drug Activation |b Lake Tahoe, Ca., USA, August 16 - 19, 1994 |c guest ed.: Chris A. Pritsos |
| 246 | 1 | 3 | |a Bioreductive drug activation |
| 264 | 1 | |a New York |b Pergamon |c 1994 | |
| 300 | |a S. 459 - 559 |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Oncology research |v 6,10/11 | |
| 500 | |a Einzelaufnahme eines Zs.-Heftes | ||
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Targeted drug delivery |0 (DE-588)4302415-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Enzymatische Reduktion |0 (DE-588)4129593-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1994 |z Stateline Nev. |2 gnd-content | |
| 689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 1 | |a Targeted drug delivery |0 (DE-588)4302415-4 |D s |
| 689 | 0 | 2 | |a Enzymatische Reduktion |0 (DE-588)4129593-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Pritsos, Chris A. |e Sonstige |4 oth | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-007056312 | |
Datensatz im Suchindex
| _version_ | 1823607492508123136 |
|---|---|
| adam_text | |
| any_adam_object | |
| author_corporate | International Conference on Bioreductive Drug Activation Tahoe City, Calif |
| author_corporate_role | aut |
| author_facet | International Conference on Bioreductive Drug Activation Tahoe City, Calif |
| author_sort | International Conference on Bioreductive Drug Activation Tahoe City, Calif |
| building | Verbundindex |
| bvnumber | BV010583554 |
| ctrlnum | (OCoLC)645862808 (DE-599)BVBBV010583554 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV010583554</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">960124s1994 xx d||| |||| 10||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)645862808</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010583554</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">International Conference on Bioreductive Drug Activation</subfield><subfield code="d">1994</subfield><subfield code="c">Tahoe City, Calif.</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)1230946-1</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Proceedings of the International Conference on Bioreductive Drug Activation</subfield><subfield code="b">Lake Tahoe, Ca., USA, August 16 - 19, 1994</subfield><subfield code="c">guest ed.: Chris A. Pritsos</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Bioreductive drug activation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Pergamon</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">S. 459 - 559</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Oncology research</subfield><subfield code="v">6,10/11</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zs.-Heftes</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Enzymatische Reduktion</subfield><subfield code="0">(DE-588)4129593-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1994</subfield><subfield code="z">Stateline Nev.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Enzymatische Reduktion</subfield><subfield code="0">(DE-588)4129593-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pritsos, Chris A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007056312</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1994 Stateline Nev. gnd-content |
| genre_facet | Konferenzschrift 1994 Stateline Nev. |
| id | DE-604.BV010583554 |
| illustrated | Illustrated |
| indexdate | 2025-02-09T19:00:28Z |
| institution | BVB |
| institution_GND | (DE-588)1230946-1 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007056312 |
| oclc_num | 645862808 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | S. 459 - 559 graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Pergamon |
| record_format | marc |
| series2 | Oncology research |
| spelling | International Conference on Bioreductive Drug Activation 1994 Tahoe City, Calif. Verfasser (DE-588)1230946-1 aut Proceedings of the International Conference on Bioreductive Drug Activation Lake Tahoe, Ca., USA, August 16 - 19, 1994 guest ed.: Chris A. Pritsos Bioreductive drug activation New York Pergamon 1994 S. 459 - 559 graph. Darst. txt rdacontent n rdamedia nc rdacarrier Oncology research 6,10/11 Einzelaufnahme eines Zs.-Heftes Cytostatikum (DE-588)4068347-3 gnd rswk-swf Targeted drug delivery (DE-588)4302415-4 gnd rswk-swf Enzymatische Reduktion (DE-588)4129593-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1994 Stateline Nev. gnd-content Cytostatikum (DE-588)4068347-3 s Targeted drug delivery (DE-588)4302415-4 s Enzymatische Reduktion (DE-588)4129593-6 s DE-604 Pritsos, Chris A. Sonstige oth |
| spellingShingle | Proceedings of the International Conference on Bioreductive Drug Activation Lake Tahoe, Ca., USA, August 16 - 19, 1994 Cytostatikum (DE-588)4068347-3 gnd Targeted drug delivery (DE-588)4302415-4 gnd Enzymatische Reduktion (DE-588)4129593-6 gnd |
| subject_GND | (DE-588)4068347-3 (DE-588)4302415-4 (DE-588)4129593-6 (DE-588)1071861417 |
| title | Proceedings of the International Conference on Bioreductive Drug Activation Lake Tahoe, Ca., USA, August 16 - 19, 1994 |
| title_alt | Bioreductive drug activation |
| title_auth | Proceedings of the International Conference on Bioreductive Drug Activation Lake Tahoe, Ca., USA, August 16 - 19, 1994 |
| title_exact_search | Proceedings of the International Conference on Bioreductive Drug Activation Lake Tahoe, Ca., USA, August 16 - 19, 1994 |
| title_full | Proceedings of the International Conference on Bioreductive Drug Activation Lake Tahoe, Ca., USA, August 16 - 19, 1994 guest ed.: Chris A. Pritsos |
| title_fullStr | Proceedings of the International Conference on Bioreductive Drug Activation Lake Tahoe, Ca., USA, August 16 - 19, 1994 guest ed.: Chris A. Pritsos |
| title_full_unstemmed | Proceedings of the International Conference on Bioreductive Drug Activation Lake Tahoe, Ca., USA, August 16 - 19, 1994 guest ed.: Chris A. Pritsos |
| title_short | Proceedings of the International Conference on Bioreductive Drug Activation |
| title_sort | proceedings of the international conference on bioreductive drug activation lake tahoe ca usa august 16 19 1994 |
| title_sub | Lake Tahoe, Ca., USA, August 16 - 19, 1994 |
| topic | Cytostatikum (DE-588)4068347-3 gnd Targeted drug delivery (DE-588)4302415-4 gnd Enzymatische Reduktion (DE-588)4129593-6 gnd |
| topic_facet | Cytostatikum Targeted drug delivery Enzymatische Reduktion Konferenzschrift 1994 Stateline Nev. |
| work_keys_str_mv | AT internationalconferenceonbioreductivedrugactivationtahoecitycalif proceedingsoftheinternationalconferenceonbioreductivedrugactivationlaketahoecausaaugust16191994 AT pritsoschrisa proceedingsoftheinternationalconferenceonbioreductivedrugactivationlaketahoecausaaugust16191994 AT internationalconferenceonbioreductivedrugactivationtahoecitycalif bioreductivedrugactivation AT pritsoschrisa bioreductivedrugactivation |